Cetuximab-conjugated sodium selenite nanoparticles for doxorubicin targeted delivery against MCF-7 breast cancer cells.
Moni SS, Abdelwahab SI, Mohan S, Riadi Y, Elmobark ME, Areshyi RW, Sofyani HA, Halawi FA, Hakami MQ, Aljahdali IA, Oraibi B, Farasani A, Dawod OY, Alfaifi HA, Alzahrani AH, Jerah AA.
Moni SS, et al. Among authors: abdelwahab si.
Nanomedicine (Lond). 2024 Oct 9:1-16. doi: 10.1080/17435889.2024.2403962. Online ahead of print.
Nanomedicine (Lond). 2024.
PMID: 39381998